NEWS

November 29, 2007 ::
ATEL Ventures infuses $4.5MM of growth capital and equity financing into Adenosine Therapeutics.

June 18, 2007 ::
Adenosine Therapeutics Announces Investment by Novartis Option Fund and Option Agreement to Develop Novel Oral Drugs for Diabetes and Asthma

June 25, 2007 ::
Adenosine Therapeutics Announces Appointment of Drs. Jonathan Sackier and Steven Tregay to the Board of Directors